Medical Membrane Device Market Report

Medical Membrane Device Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies, and Forecasts, 2015 To 2022

Format: PDF  |  Report ID: GVR2054

The global medical membrane device market is expected to show a lucrative growth over the forecast period, owing to the growing incidences of lifestyle related chronic diseases such as renal failure, diabetes, and arthrosclerosis coupled with rising demand of the membrane devices in the management of diseases. Growing number of applications of the membrane devices such as microfiltration, IV infusion filters, drug delivery and sterile filtrations is expected to show positive impact for the market growth. In addition, other non-therapeutic uses such as recovery of the concentrated proteins and enzymes are anticipated to poise the market growth during the forecast period. Introduction of the new technologies in medical membrane devices, growing awareness, and acceptance of these technologies are other drivers for the growth of medical membrane device market. Additionally increasing usage of these membranes in the fields such as water purification, food and beverages is expected to propagate scope of the membrane devices in the near future.

On the basis of scope, the medical membrane device market is segmented into therapeutic use and diagnostic use. Therapeutic segment is further classified, on the basis of diseases into renal, cardiovascular, respiratory and others. Diagnostic segment involves the tools such as proteins and enzymes filter. The therapeutic segment held the largest market share in 2014 owing to the rising prevalence of chronic disease and increasing awareness of the physicians about the applications of medical membrane devices in management of these diseases. The market share of diagnostic segment is showing the significant growth owing to the introduction of innovative methods. The demand is expected to grow substantially in both the segments in the future owing to the technological developments in the area and demand for the more efficient and economic methods for diagnosis and therapeutics of diseases . On the basis of type, the medical membrane device market is segmented into IV filters, dialyzers, blood microfilters, blood oxygenators and blood/apheresis filters. The blood/apheresis filters dominated the medical membrane device market share in 2014 owing to the growing demand of the blood components such as RBC, WBC, platelets for management of various diseases and disorders such as sickle cell anemia and thalassemia.

Geographically, the medical membrane device market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA (Middle East and Africa). In 2014, North America dominated the medical membrane device market owing to the increasing awareness of the people and growing demand of the medical membrane device supported by the sophisticated healthcare infrastructure. The dominance of North America is expected to continue in the future owing to the development in technologies in the membrane device. Asia Pacific is anticipated to show the fastest growth in this market owing to the rising demand of the medical membrane devices with rising disposable income, changing lifestyle associated chronic diseases and increasing number of dialysis centers in the developing countries like India and china. Growing interest of governments in these countries for foreign direct investments in medical device sector is expected to play an important role in the growth of medical membrane device market. In addition, increasing favorable government initiatives and programs is expected to boost the market growth during the forecast period.

Key players of the market include Abbott Laboratories, Agilent Technologies, Baxter International Inc, B. Braun Medical Inc. Fresenius Group, Gore, F.Hoffmann-La Roche AG, 3M Company, Aethlon Medical Inc, Becton, Dickinson and Company, Cantel Medical Corporation, Siemens AG, and Johnson & Johnson Services Inc. Aethlon medical Inc has come up with innovative products like Aethlon ADAPT system, hemopurifier, and HER2osome. The product portfolio of the Medivators, the subsidiary of Cantel Medical Corporation includes products such as hemocore HPH and Renaflo II HF which are majorly used in renal dialysis and therapeutic filtration technologies. Expected commercializations of new products and subsequent acquisitions and mergers of companies involved in the medical devices are the recent trends being observed in the medical membrane device market. For instance, in May 2015, Danahar announced to buy Pall which is involved in the business of purification and separation processes. 

 

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Library Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA